Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Neti Pots, Nurse Ambassadors & American Healthcare

Philip Seo, MD, MHS  |  Issue: March 2021  |  March 15, 2021

Just YouTube it.

As a rheumatologist who sees many patients with granulomatosis with polyangiitis (GPA), I have spent a significant portion of my life talking to people about neti pots.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Originally, the neti pot was part of the Ayurvedic tradition. Neti pots were used to flush the sinuses with water, milk and ghee, or to prepare the body for meditation.1 

The neti pot would have remained an Ayurvedic footnote if it were not for a brilliant cardiac surgeon from Columbia University, Mehmet Oz, MD, MBA, who appeared on a television show hosted by a former Baltimore reporter. In 2006, Dr. Oz went on The Oprah Winfrey Show to extol the health benefits of using a neti pot on a regular basis.2 The rest, as they say, was history. Endorsement by both Dr. Oz and Oprah was enough to get neti pots on the shelves of every CVS and Walgreens across the country.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For patients with GPA, medications may not be enough to keep their sinus disease under control. For many of them, an epoxy of blood and mucous adheres to their sinuses and becomes a nidus for infection. Irrigation with a neti pot, two or three times daily, is often the only intervention that brings their symptoms under control.

Most patients try to give me the benefit of the doubt, but it’s a tough sell. Further, I know if their first time using a neti pot is a disaster, they won’t hesitate to abandon it. So I provide them with some additional instruction: 

Buy a gallon of distilled water from the pharmacy. Wash out the neti pot, and fill it with water. Bring it into the bathroom with you. After a hot shower, which loosens the mucus, hold the neti pot in your dominant hand. Now breathe: nice, slow, deep breaths. 

Do you remember jumping into a pool as a kid, and trying to keep the water from running up your nose? That’s the sensation you have to fight; you have to let the water up and in. After you have a nice breathing rhythm, bring the neti pot to one nostril, lean forward, and let the water flow. If the water seems to stop at your nose, put the pot down, and try again tomorrow. When you have mastered the technique, you’re ready to start adding the salt packets.

I don’t give this tutorial as often anymore. Nowadays, more often than not, I send my patients to YouTube.

The internet has a surfeit of instructional videos on how to use a neti pot appropriately. I tell my patients to watch a few of them before they decide to try it. In part, I want them to have a solid understanding of the technique before jumping in. But I also know the videos simultaneously encourage them to dip a toe in the water. Every video starts with a convert, pot in hand, praising the Way of the Neti. Nothing is quite as convincing as a patient with chronic sinusitis or allergies talking about how sinus irrigation has changed his life. Two or three testimonials are all it takes for most patients to be willing to take the plunge.

I know that asking my patients to self-educate is not ideal, but for this particular intervention, it seems to work well enough. It also gives me back 10 minutes in an appointment, which I can use to talk about other issues that are more firmly in my wheelhouse. But what about more complicated tasks, like injecting a biologic for the first time? What resources can patients use when YouTube videos are not enough?

Enter the nurse ambassador.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:OpinionProfessional TopicsRheuminationsSpeak Out Rheum Tagged with:medication compliancenurse ambassadors

Related Articles

    Marching to the Biosimilar Beat: Questions on Rollout Remain

    September 7, 2023

    The availability of biosimilars for the treatment of patients with rheumatic diseases exploded in 2023. Here’s where we stand and what to expect going forward.

    Biosimilars Debate Heats up over Cost Savings, Safety Concerns

    Biosimilars Debate Heats up over Cost Savings, Safety Concerns

    April 15, 2016

    After years of speculation about potential cost savings and debates on safety, biosimilars are about to step onto the stage of rheumatic disease treatment. On Feb. 9, the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) met in Washington, D.C., and recommended the approval of CT-P13, a proposed biosimilar to infliximab (Remicade),…

    Report on EU’s Experience with Biosimilar Drugs Released: Will U.S. Experience Be Similar?

    October 17, 2017

    As questions about biosimilar medications swirl among U.S. rheumatologists, a recently released report sheds some light on the European experience with biosimilars—and may offer some important insights for the U.S. market. The report, Biosimilars in the EU: Information Guide for Healthcare Professionals, was released in late April by the European Medicines Agency (EMA) and the…

    The Biosimilars Debate Heats Up: Potential cost savings weighed against patient health & safety

    March 1, 2016

    After years of speculation about potential cost savings and debates on safety, biosimilars are about to step onto the stage of rheumatic disease treatment. On Feb. 9, the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) met in Washington, D.C., and recommended the approval of CT-P13, a proposed biosimilar to infliximab (Remicade),…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences